{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T05:46:04Z","timestamp":1777355164090,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,10,3]],"date-time":"2007-10-03T00:00:00Z","timestamp":1191369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1007\/s10875-007-9135-6","type":"journal-article","created":{"date-parts":[[2007,10,2]],"date-time":"2007-10-02T15:18:12Z","timestamp":1191338292000},"page":"78-84","source":"Crossref","is-referenced-by-count":28,"title":["Increased Serum Levels of Soluble CD30 in Patients with Common Variable Immunodeficiency and Its Clinical Implications"],"prefix":"10.1007","volume":"28","author":[{"given":"Nima","family":"Rezaei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Haji-Molla-Hoseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asghar","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Akbar","family":"Pourfathollah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mina","family":"Moghtadaie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Pourpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,10,3]]},"reference":[{"key":"9135_CR1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1128\/CDLI.12.7.825-832.2005","volume":"12","author":"A Aghamohammadi","year":"2005","unstructured":"Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol 2005;12:825\u201332.","journal-title":"Clin Diagn Lab Immunol"},{"key":"9135_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","volume":"92","author":"C Cunningham-Rundles","year":"1999","unstructured":"Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 1999;92:34\u201348.","journal-title":"Clin Immunol"},{"key":"9135_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2249.2000.01131.x","volume":"120","author":"L Hammarstrom","year":"2000","unstructured":"Hammarstrom L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120:225\u201331.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR4","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2222.2001.01117.x","volume":"31","author":"GP Spickett","year":"2001","unstructured":"Spickett GP. Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy 2001;31:536\u201342.","journal-title":"Clin Exp Allergy"},{"key":"9135_CR5","first-page":"103","volume":"3","author":"ADB Webster","year":"2004","unstructured":"Webster ADB. Clinical and immunological spectrum of common variable immunodeficiency (CVID). Iran J Allergy Asthma Immunol 2004;3:103\u201313.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"9135_CR6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11882-001-0027-1","volume":"1","author":"C Cunningham-Rundles","year":"2001","unstructured":"Cunningham-Rundles C. Common variable immunodeficiency. Curr Allergy Asthma Rep 2001;1:421\u20139.","journal-title":"Curr Allergy Asthma Rep"},{"key":"9135_CR7","first-page":"31","volume":"86","author":"RA Hermaszewski","year":"1993","unstructured":"Hermaszewski RA, Webster AD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med 1993;86:31\u201342.","journal-title":"Q J Med"},{"key":"9135_CR8","first-page":"135","volume":"1","author":"A Aghamohammadi","year":"2000","unstructured":"Aghamohammadi A, Moin M, Farhoudi A, Pourpak Z, Rezaei N, Abolmaali K, et al. The clinical spectrum of respiratory disease in patients with primary antibody deficiency. Iran J Allergy Asthma Immunol 2000;1:135\u201340.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"9135_CR9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1590\/S0001-37652004000400007","volume":"76","author":"CM Kokron","year":"2004","unstructured":"Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, et al. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc 2004;76:707\u201326.","journal-title":"An Acad Bras Cienc"},{"key":"9135_CR10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10238-004-0027-2","volume":"3","author":"M Renzo Di","year":"2004","unstructured":"Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clin Exp Med 2004;3:211\u20137.","journal-title":"Clin Exp Med"},{"key":"9135_CR11","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaci.2005.12.1347","volume":"117","author":"L Notarangelo","year":"2006","unstructured":"Notarangelo L, Casanova JL, Conley ME, Chapel H, Fischer A, Puck J, et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005. J Allergy Clin Immunol 2006;117:883\u201396.","journal-title":"J Allergy Clin Immunol"},{"key":"9135_CR12","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","volume":"93","author":"ME Conley","year":"1999","unstructured":"Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190\u20137.","journal-title":"Clin Immunol"},{"key":"9135_CR13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.molmed.2005.06.005","volume":"11","author":"J Bayry","year":"2005","unstructured":"Bayry J, Hermine O, Webster DA, Levy Y, Kaveri SV. Common variable immunodeficiency: the immune system in chaos. Trends Mol Med 2005;11:370\u20136.","journal-title":"Trends Mol Med"},{"key":"9135_CR14","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2249.2000.01239.x","volume":"120","author":"M Renzo Di","year":"2000","unstructured":"Di Renzo M, Zhou Z, George I, Becker K, Cunningham-Rundles C. Enhanced apoptosis of T cells in common variable immunodeficiency (CVID): role of defective CD28 co-stimulation. Clin Exp Immunol 2000;120:503\u201311.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR15","first-page":"124","volume":"72","author":"R Paganelli","year":"1988","unstructured":"Paganelli R, Capobianchi MR, Ensoli B, D\u2019Offizi GP, Facchini J, Dianzani F, et al. Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes. Clin Exp Immunol 1988;72:124\u20139.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-3083.2006.01753.x","volume":"63","author":"J Pons","year":"2006","unstructured":"Pons J, Ferrer JM, Martinez-Pomar N, Iglesias-Alzueta J, Matamoros N. Costimulatory molecules and cytokine production by T lymphocytes in common variable immunodeficiency disease. Scand J Immunol 2006;63:383\u20139.","journal-title":"Scand J Immunol"},{"key":"9135_CR17","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.4049\/jimmunol.170.11.5772","volume":"170","author":"AM Holm","year":"2003","unstructured":"Holm AM, Aukrust P, Aandahl EM, Muller F, Tasken K, Froland SS. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency\u2014involvement of protein kinase A type I. J Immunol 2003;170:5772\u20137.","journal-title":"J Immunol"},{"key":"9135_CR18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2249.1995.tb03779.x","volume":"102","author":"JM Ferrer","year":"1995","unstructured":"Ferrer JM, Iglesias J, Hernandez M, Matamoros N. Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients. Clin Exp Immunol 1995;102:286\u20139.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR19","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.4049\/jimmunol.174.8.5074","volume":"174","author":"A Isgro","year":"2005","unstructured":"Isgro A, Marziali M, Mezzaroma I, Luzi G, Mazzone AM, Guazzi V, et al. Bone marrow clonogenic capability, cytokine production, and thymic output in patients with common variable immunodeficiency. J Immunol 2005;174:5074\u201381.","journal-title":"J Immunol"},{"key":"9135_CR20","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1084\/jem.180.6.2407","volume":"180","author":"R Manetti","year":"1994","unstructured":"Manetti R, Annunziato F, Biagiotti R, Giudizi MG, Piccinni MP, Giannarini L, et al. CD30 expression by CD8+ T cells producing type 2 helper cytokines. Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 1994;180:2407\u201311.","journal-title":"J Exp Med"},{"key":"9135_CR21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/jlb.57.5.726","volume":"57","author":"S Romagnani","year":"1995","unstructured":"Romagnani S, Del Prete G, Maggi E, Chilosi M, Caligaris-Cappio F, Pizzolo G. CD30 and type 2 T helper (Th2) responses. J Leukoc Biol 1995;57:726\u201330.","journal-title":"J Leukoc Biol"},{"key":"9135_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/jlb.61.5.539","volume":"61","author":"MM D\u2019Elios","year":"1997","unstructured":"D\u2019Elios MM, Romagnani P, Scaletti C, Annunziato F, Manghetti M, Mavilia C, et al. In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. J Leukoc Biol 1997;61:539\u201344.","journal-title":"J Leukoc Biol"},{"key":"9135_CR23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/eji.1830190125","volume":"19","author":"O Josimovic-Alasevic","year":"1989","unstructured":"Josimovic-Alasevic O, Durkop H, Schwarting R, Backe E, Stein H, Diamantstein T. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay. Eur J Immunol 1989;19:157\u201362.","journal-title":"Eur J Immunol"},{"key":"9135_CR24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1096\/fasebj.9.1.7821763","volume":"9","author":"G Del Prete","year":"1995","unstructured":"Del Prete G, De Carli M, Almerigogna F, Daniel CK, D\u2019Elios MM, Zancuoghi G, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. Faseb J 1995;9:81\u20136.","journal-title":"Faseb J"},{"key":"9135_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/eji.1830260209","volume":"26","author":"M Chilosi","year":"1996","unstructured":"Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, et al. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn\u2019s syndrome: evidence for a T helper 2-mediated condition. Eur J Immunol 1996;26:329\u201334.","journal-title":"Eur J Immunol"},{"key":"9135_CR26","first-page":"1751","volume":"151","author":"C Mavalia","year":"1997","unstructured":"Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, Emmi L, et al. Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 1997;151:1751\u20138.","journal-title":"Am J Pathol"},{"key":"9135_CR27","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1349-7006.2005.00106.x","volume":"96","author":"C Nishioka","year":"2005","unstructured":"Nishioka C, Takemoto S, Kataoka S, Yamanaka S, Moriki T, Shoda M, et al. Serum level of soluble CD30 correlates with the aggressiveness of adult T-cell leukemia\/lymphoma. Cancer Sci 2005;96:810\u20135.","journal-title":"Cancer Sci"},{"key":"9135_CR28","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1034\/j.1398-9995.2001.00137.x","volume":"56","author":"A Bengtsson","year":"2001","unstructured":"Bengtsson A. The role of CD30 in atopic disease. Allergy 2001;56:593\u2013603.","journal-title":"Allergy"},{"key":"9135_CR29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1006\/smim.1998.0156","volume":"10","author":"R Horie","year":"1998","unstructured":"Horie R, Watanabe T. CD30: expression and function in health and disease. Semin Immunol 1998;10:457\u201370.","journal-title":"Semin Immunol"},{"key":"9135_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2249.2001.01647.x","volume":"126","author":"NM Keane","year":"2001","unstructured":"Keane NM, Price P, Lee S, Stone SF, French MA. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. Clin Exp Immunol 2001;126:111\u20136.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR31","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/1521-4141(200106)31:6<1927::AID-IMMU1927>3.0.CO;2-D","volume":"31","author":"A Amedei","year":"2001","unstructured":"Amedei A, Romagnani C, Benagiano M, Azzurri A, Fomia F, Torrente F, et al. Preferential Th1 profile of T helper cell responses in X-linked (Bruton\u2019s) agammaglobulinemia. Eur J Immunol 2001;31:1927\u201334.","journal-title":"Eur J Immunol"},{"key":"9135_CR32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2249.1998.00532.x","volume":"111","author":"R Giacomelli","year":"1998","unstructured":"Giacomelli R, Passacantando A, Parzanese I, Vernia P, Klidara N, Cucinelli F, et al. Serum levels of soluble CD30 are increased in ulcerative colitis (UC) but not in Crohn\u2019s disease (CD). Clin Exp Immunol 1998;111:532\u20135.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR33","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/10428190500285285","volume":"47","author":"A Aghamohammadi","year":"2006","unstructured":"Aghamohammadi A, Parvaneh N, Tirgari F, Mahjoob F, Movahedi M, Gharagozlou M, et al. Lymphoma of mucosa-associated lymphoid tissue in common variable immunodeficiency. Leuk Lymphoma 2006;47:343\u20136.","journal-title":"Leuk Lymphoma"},{"key":"9135_CR34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10875-006-9047-x","volume":"26","author":"N Rezaei","year":"2006","unstructured":"Rezaei N, Aghamohammadi A, Moin M, Pourpak Z, Movahedi M, Gharagozlou M, et al. Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian primary immunodeficiency registry. J Clin Immunol 2006;26:519\u201332.","journal-title":"J Clin Immunol"},{"key":"9135_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-0897.2006.00409.x","volume":"56","author":"N Rezaei","year":"2006","unstructured":"Rezaei N, Pourpak Z, Aghamohammadi A, Farhoudi A, Movahedi M, Gharagozlou M, et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am J Reprod Immunol 2006;56:145\u201351.","journal-title":"Am J Reprod Immunol"},{"key":"9135_CR36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2249.1996.d01-795.x","volume":"105","author":"ME North","year":"1996","unstructured":"North ME, Ivory K, Funauchi M, Webster AD, Lane AC, Farrant J. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol 1996;105:517\u201322.","journal-title":"Clin Exp Immunol"},{"key":"9135_CR37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/clin.1997.4483","volume":"86","author":"Z Zhou","year":"1998","unstructured":"Zhou Z, Huang R, Danon M, Mayer L, Cunningham-Rundles C. IL-10 production in common variable immunodeficiency. Clin Immunol Immunopathol 1998;86:298\u2013304.","journal-title":"Clin Immunol Immunopathol"},{"key":"9135_CR38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/clin.1994.1032","volume":"70","author":"P Aukrust","year":"1994","unstructured":"Aukrust P, Muller F, Froland SS. Elevated serum levels of interleukin-4 and interleukin-6 in patients with common variable immunodeficiency (CVI) are associated with chronic immune activation and low numbers of CD4+ lymphocytes. Clin Immunol Immunopathol 1994;70:217\u201324.","journal-title":"Clin Immunol Immunopathol"},{"key":"9135_CR39","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1182\/blood-2004-06-2423","volume":"105","author":"AM Holm","year":"2005","unstructured":"Holm AM, Aukrust P, Damas JK, Muller F, Halvorsen B, Froland SS. Abnormal interleukin-7 function in common variable immunodeficiency. Blood 2005;105:2887\u201390.","journal-title":"Blood"},{"key":"9135_CR40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.all.0000191888.97397.b3","volume":"5","author":"S Goldacker","year":"2005","unstructured":"Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005;5:504\u20139.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"9135_CR41","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1016\/j.vaccine.2007.05.021","volume":"25","author":"N Rezaei","year":"2007","unstructured":"Rezaei N, Aghamohammadi A, Siadat SD, Nejati M, Ahmadi H, Moin M, et al. Serum bactericidal antibody response to serogroup C polysaccharide meningococcal vaccination in children with primary antibody deficiencies. Vaccine 2007;25:5308\u201314.","journal-title":"Vaccine"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9135-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-007-9135-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-007-9135-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T00:18:36Z","timestamp":1587946716000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-007-9135-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["9135"],"URL":"https:\/\/doi.org\/10.1007\/s10875-007-9135-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,3]]}}}